French pharmaceutical company Sanofi-Aventis announced a 10-year agreement with Covance on Thursday under which the Princeton, N.J.-based contract research firm will provide it with drug development services. Sanofi-Aventis will pay Covance between $1.2 billion to $2.2 billion.
Continue reading Sanofi-Aventis Inks 10-Year R&D Services Deal with Covance
Sanofi-Aventis Inks 10-Year R&D Services Deal with Covance originally appeared on DailyFinance on Thu, 30 Sep 2010 10:37:00.
Filed Under: Health Care, Genzyme Corporation , Sanofi Aventis, Stocks in the News